Issue 79, 2018

Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles

Abstract

Novel matrix metalloproteinase 2 (MMP2)-sensitive nanoparticles (NPs) are developed with copolymers of TPGS3350-pp-PLGA and TPGS-folate to overcome some drawbacks of traditional anticancer formulations in drug delivery, such as short circulation time in blood, small drug accumulation at the tumor site, low intracellular uptake, etc.

Graphical abstract: Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
09 Jul 2018
Accepted
28 Aug 2018
First published
29 Aug 2018

Chem. Commun., 2018,54, 11092-11095

Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles

J. Pan, P. Li, Y. Wang, L. Chang, D. Wan and H. Wang, Chem. Commun., 2018, 54, 11092 DOI: 10.1039/C8CC05504A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements